All patients older than 12 years were deemed eligible for treatment if they had significant fibrosis or cirrhosis regardless of HBV DNA or ALT levels (based on clinical criteria for cirrhosis or APRI >0.5 in adults or transient elastography >7kPa). The gene discussed is GPT; the disease is fibrosis.